(84) | Designated Contracting States: | | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | | Designated Extension States: | | BA ME | | Designated Validation States: | | KH MA MD TN |
(30) | Priority: | 20.04.2017 GB 201706252 20.04.2017 GB 201706251 20.04.2017 GB 201706250 20.04.2017 GB 201706249 20.04.2017 GB 201706248 20.04.2017 GB 201706247 20.04.2017 GB 201706246 20.04.2017 GB 201706245 29.03.2018 GB 201805189
|
(71) | Applicants: | | - ADC Therapeutics SA
1066 Epalinges (CH) - Medimmune Limited
Cambridge, Cambridgeshire CB21 6GH (GB)
|
| (72) | Inventors: | | - VAN BERKEL, Patricius Hendrikus Cornelis
1066 Epalinges (CH) - SKELTON, Lisa
1066 Epalinges (CH) - ZAMMARCHI, Francesca
1066 Epalinges (CH) - FEINGOLD, Jay Marshall
Murray Hill
New Jersey 07947 (US) - WUERTHNER, Jens
1066 Epalinges (CH) - HARTLEY, John
London WC1E 6BT (GB)
|
(74) | Representative: Mewburn Ellis LLP | | City Tower
40 Basinghall Street London EC2V 5DE London EC2V 5DE (GB) |
|